This training provides research-backed communication strategies for physicians and nurses to engage patients in conversation and support COVID-19 vaccination.
Pregnant women face significantly higher risks of serious illness and death from COVID-19. Nevertheless, COVID-19 vaccination among a subset of women of childbearing age lags far behind the general population. Concerns and misinformation about the efficacy and safety of the vaccines for women who are pregnant, breastfeeding, or hoping to get pregnant in the future present a serious obstacle to vaccine compliance in these vulnerable populations.
The target audience for this activity includes physicians and nurses.
At the completion of this activity, the participant will be better able to:
- Identify strategies to initiate effective conversations about COVID-19 vaccines.
- Demonstrate principles of empathetic listening and responding to understand the patient’s perspective.
- Apply strategies to productively engage patients in learning about COVID-19 vaccination.
- Develop a clear behavioral directive to encourage vaccination.
Bruce Lambert, PhD Director, Center for Communication & Health Professor, Communication Studies Northwestern University
Melissa A. Simon, MD, MPH Professor, Obstetrics and Gynecology General Obstetrics and Gynecology Director, Institute for Public Health and Medicine
Priya Rajan, MD Associate Professor, Obstetrics and Gynecology ; Maternal Fetal Medicine
Robert L. Murphy, MD Executive Director, Robert J. Havey, MD Institute for Global Health John Philip Phair Professor of Infectious Diseases Professor of Medicine (Infectious Diseases) and McCormick School of Engineering
Stefanie Z. Demetriades, PhD Research Fellow, Center for Communication & Health School of Communication Northwestern University
Release Date: June 9, 2022
Expiration Date: June 9, 2023
Joint Accreditation Statement
Physician Continuing Medical Education
Nursing Continuing Education
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Stefanie Demetriades, PhD has no relevant financial relationships to disclose
Bruce Lambert, PhD reports he has been a consultant, advisor, speaker for Abbott and RLDatix
Robert L Murphy, MD has no relevant financial relationships to disclose
Barbara J. O’Keefe, PhD has no relevant financial relationships to disclose
Priya Rajan, MD h has no relevant financial relationships to disclose
Melissa A. Simon, MD, MPH has no relevant financial relationships to disclose
Shaunie P. Walker, RNC has no relevant financial relationships to disclose
CCO and ProCE Staff have no relevant financial relationships to disclose
Potential conflicts of interest were resolved with a peer review process provided by Shaunie P. Walker, RNC.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This CE activity is supported by Northwestern University COVID-19 Vaccine Communication and Evaluation Network (CoVAXCEN).
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.